⌘K

Login Start Free

Home/Filings/4/0001415889-24-000350

4//SEC Filing

Adler Reid G. 4

Accession 0001415889-24-000350

CIK 0001411685other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:19 PM ET

Size

10.4 KB

Accession

0001415889-24-000350

Insider Transaction Report

Form 4

Period: 2023-12-29

Vistagen Therapeutics, Inc.VTGN

Chief Legal Officer

Transactions

Award
Common Stock
2023-12-29$1.72/sh+167$287→ 11,655 total

Footnotes (1)

[F1]Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan.

Documents

2 files

Issuer

Vistagen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1

filerCIK 0001924908

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 5:19 PM ET
Size: 10.4 KB

View on SEC.gov